GB0116643D0 - Antiviral compounds - Google Patents

Antiviral compounds

Info

Publication number: GB0116643D0
Authority: GB; United Kingdom
Prior art keywords: antiviral compounds; antiviral; compounds
Prior art date: 2001-07-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Ceased

Application number

GBGB0116643.8A

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Virogen Ltd

Original Assignee

Virogen Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-09

Filing date

2001-07-09

Publication date

2001-08-29

2001-07-09 Application filed by Virogen Ltd filed Critical Virogen Ltd

2001-07-09 Priority to GBGB0116643.8A priority Critical patent/GB0116643D0/en

2001-08-29 Publication of GB0116643D0 publication Critical patent/GB0116643D0/en

2002-07-08 Priority to AU2002325312A priority patent/AU2002325312A1/en

2002-07-08 Priority to PCT/EP2002/007632 priority patent/WO2003006017A2/en

Status Ceased legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Virology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Pulmonology (AREA)
Molecular Biology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

GBGB0116643.8A 2001-07-09 2001-07-09 Antiviral compounds Ceased GB0116643D0 (en)

Priority Applications (3)

Application Number	Priority Date	Filing Date	Title
GBGB0116643.8A GB0116643D0 (en)	2001-07-09	2001-07-09	Antiviral compounds
AU2002325312A AU2002325312A1 (en)	2001-07-09	2002-07-08	Use of certain castanospermine esters in the treatment of influenza virus infections
PCT/EP2002/007632 WO2003006017A2 (en)	2001-07-09	2002-07-08	Use of certain castanospermine esters in the treatment of influenza virus infections

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GBGB0116643.8A GB0116643D0 (en)	2001-07-09	2001-07-09	Antiviral compounds

Publications (1)

Publication Number	Publication Date
GB0116643D0 true GB0116643D0 (en)	2001-08-29

Family

ID=9918105

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
GBGB0116643.8A Ceased GB0116643D0 (en)	2001-07-09	2001-07-09	Antiviral compounds

Country Status (3)

Country	Link
AU (1)	AU2002325312A1 (en)
GB (1)	GB0116643D0 (en)
WO (1)	WO2003006017A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2017192599A1 (en) *	2016-05-02	2017-11-09	Florida State University Research Foundation, Inc.	Treatment of zika virus infections using alpha-glucosidase inhibitors
US20220257604A1 (en) *	2019-03-08	2022-08-18	University Of Virginia Patent Foundation	Compositions and methods for modulating viral infections by regulating glucosylceramides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9027433D0 (en) *	1990-12-18	1991-02-06	Merrell Dow Pharma	Anti-herpes castanospermine esters
GB0110832D0 (en) *	2001-05-03	2001-06-27	Virogen Ltd	Antiviral compounds

2001
- 2001-07-09 GB GBGB0116643.8A patent/GB0116643D0/en not_active Ceased
2002
- 2002-07-08 WO PCT/EP2002/007632 patent/WO2003006017A2/en not_active Application Discontinuation
- 2002-07-08 AU AU2002325312A patent/AU2002325312A1/en not_active Abandoned

Also Published As

Publication number	Publication date
WO2003006017A3 (en)	2003-08-28
AU2002325312A1 (en)	2003-01-29
WO2003006017A2 (en)	2003-01-23

Publication	Publication Date	Title
AU2002349297A8 (en)	2003-06-17	Statin-like compounds
GB0101996D0 (en)	2001-03-14	Organtic compounds
GB0112324D0 (en)	2001-07-11	Compounds
GB0102668D0 (en)	2001-03-21	Compounds
GB0108102D0 (en)	2001-05-23	Compounds
HUP0400345A3 (en)	2007-05-29	Antiviral phosphono-pyrimidine derivatives
GB0119474D0 (en)	2001-10-03	Compounds
GB0102673D0 (en)	2001-03-21	Compounds
GB0102665D0 (en)	2001-03-21	Compounds
GB0119472D0 (en)	2001-10-03	Compounds
EP1458669A4 (en)	2008-10-29	Neuorologically-active compounds
GB0116643D0 (en)	2001-08-29	Antiviral compounds
GB0115178D0 (en)	2001-08-15	Compounds
GB0118364D0 (en)	2001-09-19	Compounds
GB0119473D0 (en)	2001-10-03	Compounds
GB0120344D0 (en)	2001-10-17	Compounds
GB0108097D0 (en)	2001-05-23	Compounds
GB0119688D0 (en)	2001-10-03	Antiviral compounds
AUPR520201A0 (en)	2001-06-14	Antiviral compounds
GB0105098D0 (en)	2001-04-18	Compounds
GB0120323D0 (en)	2001-10-17	Compounds
GB0104397D0 (en)	2001-04-11	Compounds
GB0104399D0 (en)	2001-04-11	Compounds
GB0104401D0 (en)	2001-04-11	Compounds
GB0101629D0 (en)	2001-03-07	Compounds

Legal Events

Date	Code	Title	Description
2002-10-09	AT	Applications terminated before publication under section 16(1)